BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30002106)

  • 21. Management of COPD in End-of-Life Care by Spanish Pulmonologists.
    Ecenarro PS; Iguiñiz MI; Tejada SP; Malanda NM; Imizcoz MA; Marlasca LA; Navarrete BA
    COPD; 2018 Apr; 15(2):171-176. PubMed ID: 29558226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to parse the protective, the punitive and the prejudicial in chronic opioid therapy?
    Crowley-Matoka M
    Pain; 2013 Jan; 154(1):5-6. PubMed ID: 23273100
    [No Abstract]   [Full Text] [Related]  

  • 23. [CDC guidelines for prescribing opioids for chronic pain].
    Alcántara Montero A; Sánchez Carnerero CI; Ibor Vidal PJ; Alonso Verdugo A
    Semergen; 2017; 43(4):e53-e54. PubMed ID: 27342625
    [No Abstract]   [Full Text] [Related]  

  • 24. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Commentary and rapprochement.
    Schatman ME; Darnall BD
    Pain Med; 2013 May; 14(5):619-20. PubMed ID: 23581878
    [No Abstract]   [Full Text] [Related]  

  • 26. Opioids for chronic refractory breathlessness: patient predictors of beneficial response.
    Johnson MJ; Bland JM; Oxberry SG; Abernethy AP; Currow DC
    Eur Respir J; 2013 Sep; 42(3):758-66. PubMed ID: 23258776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness--An Exploratory Study.
    Ferreira DH; Silva JP; Quinn S; Abernethy AP; Johnson MJ; Oxberry SG; Currow DC
    J Pain Symptom Manage; 2016 Feb; 51(2):247-54. PubMed ID: 26598037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nebulized morphine for relief of dyspnea due to chronic lung disease.
    Brown SJ; Eichner SF; Jones JR
    Ann Pharmacother; 2005 Jun; 39(6):1088-92. PubMed ID: 15840735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioids in prison: can we reduce their use?
    Velasco Montes J; González Díez S
    Rev Esp Sanid Penit; 2017 Dec; 19(2):68-69. PubMed ID: 28748987
    [No Abstract]   [Full Text] [Related]  

  • 30. Opioids and chronic pain in primary care.
    Brinksman S
    Br J Gen Pract; 2018 Oct; 68(675):454-455. PubMed ID: 30262604
    [No Abstract]   [Full Text] [Related]  

  • 31. Using the CDC Guideline and Tools for Opioid Prescribing in Patients with Chronic Pain.
    Dowell D; Haegerich TM
    Am Fam Physician; 2016 Jun; 93(12):970-2. PubMed ID: 27304765
    [No Abstract]   [Full Text] [Related]  

  • 32. What are we treating with opioid and sedative-hypnotic combination therapy?
    Sullivan MD
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):893-5. PubMed ID: 26098538
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnosing opioid addiction in people with chronic pain.
    Gorfinkel L; Voon P; Wood E; Klimas J
    BMJ; 2018 Sep; 362():k3949. PubMed ID: 30242012
    [No Abstract]   [Full Text] [Related]  

  • 34. Complexities of prescribing.
    de Couto JL
    Can Fam Physician; 2013 Jun; 59(6):612. PubMed ID: 23766039
    [No Abstract]   [Full Text] [Related]  

  • 35. Opioid utility for dyspnea in chronic obstructive pulmonary disease: a complicated and controversial story.
    Vozoris NT
    Ann Palliat Med; 2020 Mar; 9(2):571-578. PubMed ID: 31865744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Addressing the limitations of the CDC guideline for prescribing opioids for chronic noncancer pain.
    Busse JW; Juurlink D; Guyatt GH
    CMAJ; 2016 Dec; 188(17-18):1210-1211. PubMed ID: 27873754
    [No Abstract]   [Full Text] [Related]  

  • 37. A randomized controlled trial on the benefits and respiratory adverse effects of morphine for refractory dyspnea in patients with COPD: Protocol of the MORDYC study.
    Verberkt CA; van den Beuken-van Everdingen MH; Franssen FM; Dirksen CD; Schols JM; Wouters EF; Janssen DJ
    Contemp Clin Trials; 2016 Mar; 47():228-34. PubMed ID: 26825021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physician identification of opioid diversion: a difficult diagnosis.
    Reisfield GM; Sloan PA
    J Opioid Manag; 2012; 8(1):5-6. PubMed ID: 22479879
    [No Abstract]   [Full Text] [Related]  

  • 39. Choosing Wisely Canada recommendations.
    Kahan DM
    Can Fam Physician; 2018 May; 64(5):368. PubMed ID: 29760257
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
    Smallwood N; Le B; Currow D; Irving L; Philip J
    Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.